{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:13:28Z","timestamp":1774260808162,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"NIH\/NIAID","award":["R01AI018697"],"award-info":[{"award-number":["R01AI018697"]}]},{"name":"NIH-NCI Cancer Center","award":["P30 CA016059"],"award-info":[{"award-number":["P30 CA016059"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbrc.2019.03.120","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T14:28:34Z","timestamp":1553696914000},"page":"723-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Disintegrin and Metalloproteinase 17 is required for ILC2 responses to IL-33"],"prefix":"10.1016","volume":"512","author":[{"given":"Joseph C.","family":"Lownik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.03.120_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.169.1.443","article-title":"New IL-17 family members promote Th1 or Th2 responses in the lung: in\u00a0vivo function of the novel cytokine IL-25","volume":"169","author":"Hurst","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2019.03.120_bib2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.20051615","article-title":"Identification of an interleukin (IL)-25\u2013dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion","volume":"203","author":"Fallon","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2019.03.120_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2019.03.120_bib4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2019.03.120_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential \u201cinflammatory\u201d type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbrc.2019.03.120_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.aam5809","article-title":"S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense","volume":"359","author":"Huang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2019.03.120_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/385733a0","article-title":"Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-\u03b1","volume":"385","author":"Moss","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2019.03.120_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.semcdb.2008.09.005","article-title":"The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer","volume":"20","author":"Pruessmeyer","year":"2009","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2019.03.120_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2019.03.120_bib10","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.278.5343.1612","article-title":"IRAK (pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling","volume":"278","author":"Muzio","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2019.03.120_bib11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.8332913","article-title":"Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4","volume":"261","author":"Colotta","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2019.03.120_bib12","doi-asserted-by":"crossref","first-page":"13757","DOI":"10.1074\/jbc.270.23.13757","article-title":"Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex","volume":"270","author":"Greenfeder","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.03.120_bib13","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.179.4.2551","article-title":"IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex","volume":"179","author":"Chackerian","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2019.03.120_bib14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0167-5699(94)90217-8","article-title":"The type II \u201cdecoy\u201d receptor: a novel regulatory pathway for interleukin 1","volume":"15","author":"Colotta","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.bbrc.2019.03.120_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2012.11.006","article-title":"IL-1 receptor 2 (IL-1R2) and its role in immune regulation, Brain","volume":"32","author":"Peters","year":"2013","journal-title":"Behav. Immun."},{"key":"10.1016\/j.bbrc.2019.03.120_bib16","doi-asserted-by":"crossref","first-page":"31764","DOI":"10.1074\/jbc.272.50.31764","article-title":"Role of metalloproteases in the release of the IL-1 type II decoy receptor","volume":"272","author":"Orlando","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.03.120_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.febslet.2012.03.012","article-title":"The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II","volume":"586","author":"Lorenzen","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2019.03.120_bib18","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.4049\/jimmunol.165.6.3350","article-title":"The membrane form of the type II IL-1 receptor accounts for inhibitory function","volume":"165","author":"Neumann","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2019.03.120_bib19","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.4049\/jimmunol.161.12.6871","article-title":"The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness","volume":"161","author":"Lang","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2019.03.120_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000072271","article-title":"Dynamic patterned expression of orphan nuclear receptor genes ROR\u03b1 and ROR\u03b2 in developing mouse forebrain","volume":"25","author":"Nakagawa","year":"2003","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.bbrc.2019.03.120_bib21","first-page":"ji1700833","article-title":"ADAM10-Mediated ICOS ligand shedding on B cells is necessary for proper T cell ICOS regulation and T follicular helper responses","author":"Lownik","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2019.03.120_bib22","doi-asserted-by":"crossref","first-page":"e0124331","DOI":"10.1371\/journal.pone.0124331","article-title":"Increased B cell ADAM10 in allergic patients and Th2 prone mice","volume":"10","author":"Cooley","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2019.03.120_bib23","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/mi.2016.20","article-title":"IL-27 suppresses type 2 immune responses in\u00a0vivo via direct effects on group 2 innate lymphoid cells","volume":"9","author":"Mchedlidze","year":"2016","journal-title":"Mucosal Immunol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1930511X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1930511X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:36:15Z","timestamp":1762094175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1930511X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0006291X1930511X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.03.120","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Disintegrin and Metalloproteinase 17 is required for ILC2 responses to IL-33","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.03.120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}